SAN FRANCISCO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a foc ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min With a long wait list, the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Country club due increases have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback